Breakdown of surgical outcomes based on timing of anti-TNF commencement within 18 months of diagnosis in cohort of 418 pediatric patients with Crohn’s disease, comparing patients defined as high or low risk at diagnosis.
Surgical timing . | High risk (%), n = 224 . | Low risk (%), n = 194 . | P value . |
---|---|---|---|
Total | 37/224 (17) | 6/194 (3) | .01 |
Pre-anti-TNF | 22/37 (59) | 2/6 (33) | .38 |
Post-anti-TNF | 11/37 (30) | 2/6 (33) | .99 |
Without anti-TNF | 4/37 (11) | 2/6 (34) | .19 |
Surgical timing . | High risk (%), n = 224 . | Low risk (%), n = 194 . | P value . |
---|---|---|---|
Total | 37/224 (17) | 6/194 (3) | .01 |
Pre-anti-TNF | 22/37 (59) | 2/6 (33) | .38 |
Post-anti-TNF | 11/37 (30) | 2/6 (33) | .99 |
Without anti-TNF | 4/37 (11) | 2/6 (34) | .19 |
Breakdown of surgical outcomes based on timing of anti-TNF commencement within 18 months of diagnosis in cohort of 418 pediatric patients with Crohn’s disease, comparing patients defined as high or low risk at diagnosis.
Surgical timing . | High risk (%), n = 224 . | Low risk (%), n = 194 . | P value . |
---|---|---|---|
Total | 37/224 (17) | 6/194 (3) | .01 |
Pre-anti-TNF | 22/37 (59) | 2/6 (33) | .38 |
Post-anti-TNF | 11/37 (30) | 2/6 (33) | .99 |
Without anti-TNF | 4/37 (11) | 2/6 (34) | .19 |
Surgical timing . | High risk (%), n = 224 . | Low risk (%), n = 194 . | P value . |
---|---|---|---|
Total | 37/224 (17) | 6/194 (3) | .01 |
Pre-anti-TNF | 22/37 (59) | 2/6 (33) | .38 |
Post-anti-TNF | 11/37 (30) | 2/6 (33) | .99 |
Without anti-TNF | 4/37 (11) | 2/6 (34) | .19 |
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.